To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

NCT01934205 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Bacterial

Interventions

DRUG: GSK2140944 (Single dose)
DRUG: GSK2140944 (Multiple dose)

Sponsor

GlaxoSmithKline